News
A combination of lisocabtagene maraleucel (liso-cel, Breyanzi) plus ibrutinib (Imbruvica) demonstrated a trend for better ...
Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback